Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kisunla
Pharma
Anti-amyloid Alzheimer's drugs show 'trivial' effects: report
The anti-amyloid drug class has yielded some FDA approvals and plenty of failures. A new analysis sheds light on how the meds have fared overall.
Eric Sagonowsky
Apr 16, 2026 11:36am
Eli Lilly signs up Julianne Moore for brain health campaign
Sep 10, 2025 9:00am
Lilly’s Kisunla shines in first DTC ad for Alzheimer's med
Aug 20, 2025 1:11pm
Lilly's Kisunla, Gilead's PrEP drug Yeytuo gain CHMP nods
Jul 25, 2025 11:03am
FDA clears Lilly’s new Kisunla regimen with fewer side effects
Jul 9, 2025 6:45am
ExCellThera's novel blood cancer cell therapy gains CHMP nod
Jun 20, 2025 11:55am
